Centene Is Finally Showing Some Bullish Divergences
It is early in the game but here's what traders can do.
Abbott Labs Has Concocted a Way to Advance Further
The medical device and health care company is set to resume its long advance, with our first price target at $92 and next at $100.
Medtronic Operating Toward Renewed Gains
After correction, the medical device maker could see longer-term gains to the $150-$161 area.
Edwards Lifesciences Breaks Out to a New High
If you are not already long EW or just want to add to longs you should use any minor intraday dip today or tomorrow to buy.
Intuitive Surgical's Charts Are Bullish, Here's Our Strategy for Profits
Let's review the charts and indicators of ISRG.
PetMed Express Is an Investor's Best Friend
PETS has generated positive operating cash flow for more than a decade and it has been using that cash flow to pay dividends to shareholders.
Tandem Diabetes Care Could Eventually Break Out on the Upside
Traders and investors can approach TNDM from the long side.
7 Healthcare REITs With the Right Prescription for Growth and Income
These names should benefit from the aging of the population and the increasing use of medical and healthcare facilities.
6 Top Biopharmaceutical Stock Picks You Should Know About
The aging population is creating a massive tailwind for companies that provide cutting-edge health care.
Trading During Earnings Season
The most important thing to remember about trading earnings is that you do not have to hold a stock into its report in order to find good trade entries.